Brian Nappi | SVP, Strategy
Saol Therapeutics

Brian joined Saol Therapeutics in 2017 as the Senior Vice President of Commercial Operations.  He brings over 30 years of experience in the pharmaceutical industry and in 2019, assumed additional responsibilities as Senior Vice President, Strategy, overseeing the Commercial and Medical Affairs departments at Saol. Prior to his time with Saol, Brian spent nine years in senior leadership roles with Actelion Pharmaceuticals, Inc., most recently serving as the Senior Vice President of Marketing and Commercial Analytics, responsible for marketing, marketing operations, analytics and market research for the Pulmonary Arterial Hypertension (PAH) Franchise.  Brian has also held strategic commercial roles of increasing responsibility at GlaxoSmithKline, Ortho-McNeil and Johnson & Johnson. He holds a Bachelor of Science degree in Finance from the University of South Florida, and a Master of Business Administration from Florida Atlantic University.